| abstract |
The invention comprises novel compounds that are effective in the prophylaxi s and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as .alpha.v.beta.3, .alpha.v.beta.5, .alpha.v.beta.6, .alpha.5.beta.1 and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes. |